A detailed history of Quadrant Capital Group LLC transactions in Liva Nova PLC stock. As of the latest transaction made, Quadrant Capital Group LLC holds 384 shares of LIVN stock, worth $20,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
384
Previous 384 -0.0%
Holding current value
$20,163
Previous $21,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$43.45 - $53.66 $5,387 - $6,653
-124 Reduced 24.41%
384 $19,000
Q3 2023

Nov 14, 2023

SELL
$50.12 - $58.87 $12,179 - $14,305
-243 Reduced 32.36%
508 $26,000
Q2 2023

Aug 09, 2023

BUY
$42.28 - $51.43 $26,002 - $31,629
615 Added 452.21%
751 $38,000
Q1 2023

May 11, 2023

SELL
$40.84 - $58.14 $12,497 - $17,790
-306 Reduced 69.23%
136 $5,000
Q4 2022

Feb 10, 2023

BUY
$43.88 - $56.16 $7,591 - $9,715
173 Added 64.31%
442 $24,000
Q3 2022

Nov 10, 2022

BUY
$48.37 - $66.5 $12,576 - $17,290
260 Added 2888.89%
269 $14,000
Q2 2022

Aug 09, 2022

SELL
$57.25 - $86.63 $7,213 - $10,915
-126 Reduced 93.33%
9 $1,000
Q1 2022

May 06, 2022

BUY
$71.02 - $86.99 $9,587 - $11,743
135 New
135 $11,000
Q4 2021

Feb 01, 2022

SELL
$76.72 - $92.68 $2,378 - $2,873
-31 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$76.02 - $88.62 $304 - $354
4 Added 14.81%
31 $2,000
Q2 2020

Aug 13, 2020

SELL
$39.87 - $56.9 $16,506 - $23,556
-414 Reduced 93.88%
27 $1,000
Q1 2020

May 15, 2020

SELL
$34.22 - $76.49 $22,790 - $50,942
-666 Reduced 60.16%
441 $20,000
Q4 2019

Feb 03, 2020

BUY
$68.92 - $85.27 $482 - $596
7 Added 0.64%
1,107 $82,000
Q2 2019

Jul 24, 2019

BUY
$66.45 - $97.36 $37,544 - $55,008
565 Added 105.61%
1,100 $79,000
Q1 2019

Apr 29, 2019

BUY
$86.15 - $100.49 $43,591 - $50,847
506 Added 1744.83%
535 $50,000
Q3 2017

Oct 13, 2017

BUY
$60.32 - $70.06 $1,749 - $2,031
29
29 $2,000

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.81B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.